ReNeuron GroupCompany research
Click on headlines below to download research
Extension trial back on track but with data delay
ReNeuron Group | 15/07/2021
The key news in the FY21 results statement was the restart of the Phase IIa (2m cell dose) extension study after a June safety halt due to a presumed intraocular…
Short delay to hRP trial, data now likely in Q421
ReNeuron Group | 18/06/2021
There has been a safety halt to the lead human retinal progenitor cell (hRPC) project. The issue was an eye infection in one patient following a successful…